Profile data is unavailable for this security.
About the company
CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
- Revenue in USD (TTM)1.24bn
- Net income in USD64.46m
- Incorporated2020
- Employees4.00k
- LocationConmed Corp11311 Concept BoulevardLARGO 33773United StatesUSA
- Phone+1 (727) 214-2974
- Fax+1 (302) 655-5049
- Websitehttps://www.conmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs Holdings Inc | 165.15m | -78.50m | 1.44bn | 908.00 | -- | 74.55 | -- | 8.74 | -3.05 | -3.05 | 6.45 | 0.7051 | 0.6886 | 1.00 | 4.01 | 181,884.40 | -32.73 | -33.22 | -40.93 | -41.12 | 64.78 | 64.73 | -47.53 | -43.19 | 1.67 | -13.08 | 0.9112 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Inmode Ltd | 492.05m | 197.92m | 1.47bn | 581.00 | 7.52 | 1.85 | 7.39 | 2.98 | 2.30 | 2.30 | 5.73 | 9.38 | 0.6527 | 1.90 | 14.19 | 846,898.40 | 26.25 | 31.32 | 29.07 | 35.64 | 83.60 | 84.46 | 40.22 | 39.65 | 12.48 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| UFP Technologies Inc | 400.07m | 44.92m | 1.66bn | 3.09k | 37.32 | 5.81 | 29.54 | 4.16 | 5.84 | 5.84 | 51.97 | 37.45 | 1.02 | 4.65 | 6.69 | 129,347.20 | 11.48 | 9.69 | 13.45 | 10.95 | 28.05 | 26.33 | 11.23 | 10.14 | 1.28 | 15.86 | 0.101 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Alphatec Holdings Inc | 482.26m | -186.64m | 1.70bn | 839.00 | -- | 22.00 | -- | 3.53 | -1.54 | -1.54 | 3.98 | 0.7305 | 0.7273 | 1.44 | 7.06 | 574,805.80 | -28.15 | -30.97 | -36.25 | -39.47 | 64.32 | 66.02 | -38.70 | -46.22 | 1.99 | -5.40 | 0.8345 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Owens & Minor, Inc. | 10.33bn | -41.30m | 1.84bn | 13.70k | -- | 1.99 | 7.49 | 0.1783 | -0.5479 | -0.5479 | 136.31 | 12.07 | 1.97 | 6.72 | 15.18 | 754,304.20 | -0.7882 | 1.32 | -1.18 | 2.07 | 20.56 | 16.48 | -0.3997 | 0.5614 | 0.5244 | 2.04 | 0.6944 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Tandem Diabetes Care Inc | 747.72m | -222.61m | 2.03bn | 2.40k | -- | 6.46 | -- | 2.71 | -3.44 | -3.44 | 11.51 | 4.78 | 0.7457 | 2.82 | 6.79 | 311,549.20 | -22.20 | -10.08 | -27.07 | -12.23 | 49.17 | 51.77 | -29.77 | -11.59 | 3.02 | -- | 0.4761 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| Conmed Corp | 1.24bn | 64.46m | 2.19bn | 4.00k | 34.83 | 2.62 | 16.05 | 1.76 | 2.04 | 2.04 | 39.67 | 27.12 | 0.5415 | 1.75 | 5.74 | 311,185.80 | 2.80 | 0.8972 | 3.23 | 1.02 | 54.33 | 54.95 | 5.18 | 1.65 | 0.9569 | 3.03 | 0.5386 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
| Inari Medical Inc | 493.63m | -1.64m | 2.24bn | 1.30k | -- | 4.80 | 426.26 | 4.54 | -0.0318 | -0.0318 | 8.60 | 8.05 | 0.8378 | 1.57 | 7.67 | 379,716.90 | -0.2777 | -0.5941 | -0.3129 | -0.6696 | 88.03 | 89.06 | -0.3314 | -0.6295 | 2.52 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.28bn | 7.60k | 12.56 | 2.36 | 8.15 | 0.3475 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
| STAAR Surgical Co | 322.42m | 21.35m | 2.29bn | 1.06k | 108.18 | 5.92 | 85.83 | 7.09 | 0.4324 | 0.4324 | 6.53 | 7.90 | 0.7106 | 2.35 | 4.10 | 305,317.30 | 4.70 | 6.77 | 5.40 | 7.90 | 78.36 | 76.89 | 6.62 | 9.16 | 5.08 | -- | 0.0005 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Helen of Troy Limited | 2.00bn | 162.04m | 2.34bn | 1.90k | 14.55 | 1.47 | 11.10 | 1.17 | 6.76 | 6.76 | 83.27 | 66.81 | 0.6579 | 2.25 | 4.13 | 1,051,199.00 | 5.33 | 8.62 | 6.46 | 10.82 | 45.95 | 43.16 | 8.10 | 9.72 | 0.9755 | 4.82 | 0.3168 | -- | -6.78 | 6.98 | -35.97 | -0.488 | 66.65 | -- |
| ICU Medical Inc | 2.26bn | -29.66m | 2.36bn | 14.00k | -- | 1.10 | 11.79 | 1.05 | -1.23 | -1.23 | 93.55 | 87.96 | 0.5080 | 2.16 | 11.79 | 161,366.10 | -0.6669 | 1.46 | -0.7491 | 1.65 | 32.75 | 34.11 | -1.31 | 2.23 | 1.06 | 0.6484 | 0.4345 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Premier Inc | 1.32bn | 167.33m | 2.49bn | 2.80k | 14.91 | 1.04 | 8.47 | 1.89 | 1.39 | 1.39 | 10.97 | 19.95 | 0.3571 | 4.57 | 3.06 | 470,033.20 | 4.42 | 10.39 | 5.67 | 13.00 | 67.13 | 62.04 | 12.37 | 22.60 | 1.32 | 516.34 | 0.2431 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Procept Biorobotics Corp | 136.19m | -105.90m | 2.60bn | 626.00 | -- | 9.24 | -- | 19.11 | -2.24 | -2.24 | 2.88 | 5.53 | 0.3815 | 1.91 | 4.28 | 217,557.50 | -29.66 | -- | -33.47 | -- | 52.17 | -- | -77.75 | -- | 6.77 | -- | 0.1546 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| LivaNova PLC | 1.15bn | 17.55m | 2.85bn | 2.90k | 163.73 | 2.23 | 41.95 | 2.47 | 0.3222 | 0.3222 | 21.32 | 23.70 | 0.4883 | 2.76 | 5.79 | 397,774.10 | 0.7472 | -6.01 | 0.8627 | -7.42 | 66.86 | 66.99 | 1.53 | -13.56 | 2.51 | 1.10 | 0.3147 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
| TransMedics Group Inc | 241.62m | -25.03m | 2.87bn | 584.00 | -- | 20.77 | -- | 11.86 | -0.7685 | -0.7685 | 7.43 | 4.20 | 0.4915 | 2.70 | 5.30 | 413,738.00 | -5.09 | -16.08 | -5.53 | -17.95 | 63.77 | 65.37 | -10.36 | -40.47 | 8.49 | -- | 0.7868 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Data as of Apr 19 2024. Currency figures normalised to Conmed Corp's reporting currency: US Dollar USD
59.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2023 | 4.62m | 15.00% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 3.33m | 10.82% |
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 2.76m | 8.96% |
| EARNEST Partners LLCas of 31 Dec 2023 | 2.35m | 7.62% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.19m | 3.86% |
| Champlain Investment Partners LLCas of 31 Dec 2023 | 957.33k | 3.11% |
| Loomis, Sayles & Co. LPas of 31 Dec 2023 | 811.60k | 2.64% |
| Managed Account Advisors LLCas of 31 Dec 2023 | 803.13k | 2.61% |
| Macquarie Investment Management Business Trustas of 31 Dec 2023 | 745.39k | 2.42% |
| Threadneedle Asset Management Ltd.as of 31 Dec 2023 | 726.43k | 2.36% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
